Multicentre patient studies

Professional clinical development support for your multicentre phase 1–2 trials

Nuvisan conducts small multicentre clinical trials in patient populations. A pivotal step in early clinical development is the proof-of-concept (PoC) study in patients and it is crucial to meet this milestone as early as possible. Nuvisan provides all the services needed to help make your drug development a success story.

We deliver comprehensive product development services for multicentre phase 1–2 clinical research studies for investigational medicinal products (IMPs) (e.g. biologics) and medical devices. With a strong foundation in clinical trial conduct and extensive expertise, we support our clients in overcoming the challenges and complexities of conducting clinical programs.